Bade BC, Dela Cruz CS (2020) Lung Cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med 41(1):1–24

Article  PubMed  Google Scholar 

Bolandi N, Derakhshani A, Hemmat N, Baghbanzadeh A, Asadzadeh Z, Afrashteh Nour M, Brunetti O, Bernardini R, Silvestris N, Baradaran B (2021) The positive and negative immunoregulatory role of B7 family: promising novel targets in gastric cancer treatment. Int J Mol Sci 22(19):10719

Burova E, Hermann A, Waite J et al (2017) Characterization of the anti-PD-1 antibody REGN2810 and its antitumor activity in human PD-1 knock-in mice. Mol Cancer Ther 16(5):861–870

Article  CAS  PubMed  Google Scholar 

Cha JH, Chan LC, Li CW et al (2019) Mechanisms controlling PD-L1 expression in cancer. Mol Cell 76(3):359–370

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen EJ, Chen S, Zhou FL (2021) Mechanism of TRIM27 promoting inflammatory response in lung cancer cells. Zhonghua Zhong Liu Za Zhi 43(10):1076–1081

CAS  PubMed  Google Scholar 

Dong ZY, Zhong WZ, Zhang XC et al (2017) Potential predictive value of TP53 and KRAS mutation status for response to PD-1 blockade immunotherapy in lung adenocarcinoma. Clin Cancer Res 23(12):3012–3024

Article  CAS  PubMed  Google Scholar 

Ferlay J, Colombet M, Soerjomataram I et al (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144(8):1941–1953

Article  CAS  PubMed  Google Scholar 

Gómez-Henao W, Tenorio EP, Sanchez FRC et al (2021) Relevance of glycans in the interaction between T lymphocyte and the antigen presenting cell. Int Rev Immunol 40(4):274–288

Article  PubMed  Google Scholar 

Herbst RS, Morgensztern D, Boshoff C (2018) The biology and management of non-small cell lung cancer. Nature 553(7689):446–454

Article  CAS  PubMed  Google Scholar 

Hughes PE, Caenepeel S, Wu LC (2016) Targeted therapy and checkpoint immunotherapy combinations for the treatment of cancer. Trends Immunol 37(7):462–476

Lagou V, Garcia-Perez JE, Smets I et al (2018) Genetic architecture of adaptive immune system identifies key immune regulators. Cell Rep 25(3):798–810.e6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leng C, Li Y, Qin J et al (2016) Relationship between expression of PD-L1 and PD-L2 on esophageal squamous cell carcinoma and the antitumor effects of CD8+ T cells. Oncol Rep 35(2):699–708

Article  CAS  PubMed  Google Scholar 

Liu C, Zheng S, Jin R et al (2020) The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity. Cancer Lett 470:95–105

Article  CAS  PubMed  Google Scholar 

McDermott DF, Atkins MB (2013) PD-1 as a potential target in cancer therapy. Cancer Medicine 2(5):662–673

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mezzadra R, Sun C, Jae LT et al (2017) Identification of CMTM6 and CMTM4 as PD-L1 protein regulators. Nature 549(7670):106–110

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mogi A, Kuwano H (2011) TP53 mutations in nonsmall cell lung cancer. J Biomed Biotechnol 2011:583929

Article  PubMed  PubMed Central  Google Scholar 

Raphael I, Joern RR, Forsthuber TG (2020) Memory CD4+ T cells in immunity and autoimmune diseases. Cells 9(3):531

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ritchie ME, Phipson B, Wu D et al (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47

Article  PubMed  PubMed Central  Google Scholar 

Roulleaux Dugage M, Nassif EF, Italiano A et al (2021) Improving immunotherapy efficacy in soft-tissue sarcomas: a biomarker driven and histotype tailored review. Front Immunol 12:775761

Article  PubMed  PubMed Central  Google Scholar 

Salmaninejad A, Valilou SF, Shabgah AG et al (2019) PD-1/PD-L1 pathway: basic biology and role in cancer immunotherapy. J Cell Physiol 234(10):16824–16837

Article  CAS  PubMed  Google Scholar 

Singh AK, Stock P, Akbari O (2011) Role of PD-L1 and PD-L2 in allergic diseases and asthma. Allergy 66(2):155–162

Article  CAS  PubMed  Google Scholar 

Sun Y, Jiang L, Wen T et al (2021) Trends in the research into immune checkpoint blockade by anti-PD1/PDL1 antibodies in cancer immunotherapy: a bibliometric study. Front Pharmacol 12:670900

Article  CAS  PubMed  PubMed Central  Google Scholar 

Toumazis I, Bastani M, Han SS et al (2020) Risk-based lung cancer screening: a systematic review. Lung Cancer 147:154–186

Article  PubMed  Google Scholar 

Tumeh PC, Harview CL, Yearley JH et al (2014) PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515(7528):568–571

Article  CAS  PubMed  PubMed Central  Google Scholar 

Watza D, Lusk CM, Dyson G et al (2018) Prognostic modeling of the immune-centric transcriptome reveals interleukin signaling candidates contributing to differential patient outcomes. Carcinogenesis 39(12):1447–1454

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wei W, Zeng H, Zheng R et al (2020) Cancer registration in China and its role in cancer prevention and control. Lancet Oncol 21(7):e342–e3e9

Article  PubMed  Google Scholar 

Xu F, Lin H, He P et al (2020) A TP53-associated gene signature for prediction of prognosis and therapeutic responses in lung squamous cell carcinoma. Oncoimmunology 9(1):1731943

Article  PubMed  PubMed Central  Google Scholar 

Yu G, Wang LG, Han Y et al (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. Omics 16(5):284–287

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou J, Zhang D, Zhang W (2023) Cross-view enhancement network for underwater images. Eng Appl Artif Intel 121:105952

Article  Google Scholar